We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
AUM
$348M
AUM Growth
+$9.28M
Cap. Flow
-$1.75M
Cap. Flow %
-0.5%
Top 10 Hldgs %
55.68%
Holding
47
New
2
Increased
20
Reduced
9
Closed
11

Top Buys

Rank Stock Value
1
CB icon
Chubb
CB
+$9.8M
2
SPB icon
Spectrum Brands
SPB
+$5.57M
3
DEI icon
Douglas Emmett
DEI
+$5.26M
4
NFE icon
New Fortress Energy
NFE
+$4.49M
5
PRGO icon
Perrigo
PRGO
+$3.47M

Top Sells

Rank Stock Value
1
ARES icon
Ares Management
ARES
+$8.04M
2
RDN icon
Radian Group
RDN
+$5.72M
3
EQH icon
Equitable Holdings
EQH
+$5.44M
4
LEN icon
Lennar Class A
LEN
+$4.73M
5
SNY icon
Sanofi
SNY
+$4.57M

Sector Composition

Rank Sector Weight
1 Financials 53.83%
2 Healthcare 18.75%
3 Consumer Staples 9.03%
4 Real Estate 8.93%
5 Communication Services 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLX icon
1
Sixth Street Specialty
TSLX
$1.59B
$25M 7.16%
1,335,030
+58,844
+5% +$1.07M
SPB icon
2
Spectrum Brands
SPB
$2.04B
$24.6M 7.08%
315,726
+78,018
+33% +$5.57M
VTRS icon
3
Viatris
VTRS
$20.1B
$21.6M 6.21%
2,166,724
+21,255
+1% +$203K
BXSL icon
4
Blackstone Secured Lending
BXSL
$5.41B
$19.7M 5.65%
719,371
-132,354
-16% -$3.41M
BBDC icon
5
Barings BDC
BBDC
$862M
$19.4M 5.57%
2,474,570
+225,137
+10% +$1.73M
RDN icon
6
Radian Group
RDN
$5.14B
$19.1M 5.48%
755,000
-232,500
-24% -$5.72M
KKR icon
7
KKR & Co
KKR
$89.2B
$18.4M 5.3%
329,321
-20,679
-6% -$1.08M
GSK icon
8
GSK
GSK
$103B
$16M 4.61%
450,000
OWL icon
9
Blue Owl Capital
OWL
$6.39B
$16M 4.6%
1,375,000
+244,812
+22% +$2.63M
SNY icon
10
Sanofi
SNY
$104B
$14M 4.02%
260,000
-85,000
-25% -$4.57M
CCI icon
11
Crown Castle
CCI
$32.7B
$13M 3.73%
114,103
-28,897
-20% -$3.44M
PNNT
12
Pennant Park Investment Corp
PNNT
$215M
$11.8M 3.38%
2,000,000
+125,000
+7% +$676K
CMCSA icon
13
Comcast
CMCSA
$79.1B
$11.1M 3.19%
267,500
+62,500
+30% +$2.48M
CB icon
14
Chubb
CB
$140B
$9.63M 2.76%
+50,000
New +$9.8M
CG icon
15
Carlyle Group
CG
$16.3B
$8.79M 2.52%
275,000
+50,000
+22% +$1.46M
BMY icon
16
Bristol-Myers Squibb
BMY
$127B
$7.67M 2.2%
120,000
+35,000
+41% +$2.35M
DEI icon
17
Douglas Emmett
DEI
$2.06B
$7.35M 2.11%
585,000
+435,000
+290% +$5.26M
EQH icon
18
Equitable Holdings
EQH
$13.1B
$7.2M 2.07%
265,000
-215,000
-45% -$5.44M
FSK icon
19
FS KKR Capital
FSK
$2.98B
$7.19M 2.07%
375,000
OBDC icon
20
Blue Owl Capital
OBDC
$5.35B
$7.05M 2.02%
525,000
OVV icon
21
Ovintiv
OVV
$17.5B
$6.98M 2%
183,333
+58,333
+47% +$2.11M
MO icon
22
Altria Group
MO
$122B
$6.79M 1.95%
150,000
+35,000
+30% +$1.59M
NFE icon
23
New Fortress Energy
NFE
$101M
$6.03M 1.73%
225,000
+155,000
+221% +$4.49M
PRGO icon
24
Perrigo
PRGO
$1.4B
$5.94M 1.71%
175,000
+100,000
+133% +$3.47M
CCAP icon
25
Crescent Capital BDC
CCAP
$399M
$5.68M 1.63%
375,000
+50,000
+15% +$701K

Similar funds

Callodine Capital Management's Q2 2023 Portfolio in Review

As of Q2 2023, Callodine Capital Management held 47 positions worth $348M, up 2.7% from $339M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Callodine Capital Management's Q2 2023 filing shows 2 new, 20 increased, 9 reduced and 11 closed positions. Its largest new stake was Chubb: 50,000 shares worth $9.63M. The largest sale was Ares Management, an estimated $8.04M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, up from 52% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Callodine Capital Management's largest Q2 2023 buy was Chubb: 50,000 shares worth $9.63M.
  • Callodine Capital Management added most to Spectrum Brands in Q2 2023, an estimated $5.57M increase.
  • Callodine Capital Management's biggest Q2 2023 reduction was Radian Group, cutting an estimated $5.72M.
  • Callodine Capital Management fully exited Ares Management in Q2 2023, selling an estimated $8.04M.
  • Callodine Capital Management's ten largest holdings make up 56% of its $348M portfolio in Q2 2023.
  • Callodine Capital Management opened 2 new positions and closed 11 in Q2 2023.
  • Callodine Capital Management's portfolio value rose 2.7% quarter-over-quarter to $348M.

Based on Callodine Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.